Research Paper Volume 15, Issue 17 pp 8851—8872
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
Figure 9. Associations between AKAP8L expression and the DSS in different clinical subgroups of KIRC. (A) Age > 60; (B) Race: White; (C) Serum calcium: Low; (D) Hemoglobin: Low; (E) N stage: N0; (F) M stage: M1; (G) T stage: T3&T4; (H) Histologic grade: G3&G4; (I) Pathologic stage: Stage III & Stage IV.